PROPYLHEXEDRINE

PROPYLHEXEDRINE was reported 58 times

PROPYLHEXEDRINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ANION GAP ABNORMAL 4 0.0149
1 ANION GAP 5 0.0079
2 CENTRAL NERVOUS SYSTEM STIMULATION 1 0.0056
3 HOMELESS 2 0.0045
4 SUBSTANCE ABUSER 1 0.0044
5 HYPERREFLEXIA 7 0.0020
6 UNINTENTIONAL USE FOR UNAPPROVED INDICATION 1 0.0017
7 CEREBRAL VASOCONSTRICTION 1 0.0014
8 AMPHETAMINES POSITIVE 1 0.0013
9 CARDIAC VENTRICULAR THROMBOSIS 1 0.0008
10 RESPIRATORY DEPRESSION 9 0.0007
11 SUBSTANCE USE 1 0.0006
12 CARDIAC DISCOMFORT 1 0.0005
13 EUPHORIC MOOD 5 0.0005
14 LIPODYSTROPHY ACQUIRED 1 0.0005
15 SUBSTANCE-INDUCED PSYCHOTIC DISORDER 1 0.0004
16 ALCOHOL ABUSE 1 0.0004
17 PNEUMONIA ASPIRATION 9 0.0004
18 FAMILY STRESS 1 0.0003
19 METABOLIC ACIDOSIS 9 0.0003
20 PARANASAL SINUS HYPERSECRETION 1 0.0003
21 SELF-MEDICATION 1 0.0002
22 DEPRESSED LEVEL OF CONSCIOUSNESS 8 0.0002
23 NYSTAGMUS 1 0.0002
24 BEHAVIOUR DISORDER 1 0.0002
25 BLOOD PRESSURE INADEQUATELY CONTROLLED 1 0.0002
26 DRUG ABUSER 1 0.0002
27 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 1 0.0002
28 POST-TRAUMATIC STRESS DISORDER 1 0.0001
29 COMA 7 0.0001
30 DRUG ABUSE 11 0.0001
31 DISSOCIATION 1 0.0001
32 DELUSION 2 0.0001
33 DRUG SCREEN POSITIVE 1 0.0001
34 PARANOIA 2 0.0001
35 CARDIOTOXICITY 1 0.0001
36 LEUKAEMIA 1 0.0001
37 PRODUCT PACKAGING ISSUE 1 0.0001
38 TACHYCARDIA 9 0.0001
39 BRAIN INJURY 1 0.0001
40 HYPERTENSIVE CRISIS 1 0.0001
41 SCHIZOPHRENIA 1 0.0001
42 QUALITY OF LIFE DECREASED 1 0.0001
43 CENTRAL NERVOUS SYSTEM LESION 1 0.0001
44 RESPIRATORY ARREST 2 0.0001
45 DRUG DEPENDENCE 11 0.0001
46 PSYCHOTIC DISORDER 2 0.0001
47 ACUTE KIDNEY INJURY 10 0.0001
48 MANIA 1 0.0001
49 TOXICITY TO VARIOUS AGENTS 10 0.0001
50 NEUROTOXICITY 1 0.0001
51 ISCHAEMIC STROKE 1 0.0001
52 TREMOR 8 0.0000
53 INTENTIONAL PRODUCT MISUSE 4 0.0000
54 TOOTH DISORDER 1 0.0000
55 HYPOTENSION 9 0.0000
56 HEART RATE IRREGULAR 1 0.0000
57 PRODUCT AVAILABILITY ISSUE 1 0.0000
58 PRODUCT COMPLAINT 1 0.0000
59 RESPIRATORY DISORDER 1 0.0000
60 LIMB DISCOMFORT 1 0.0000
61 RASH MACULAR 1 0.0000
62 RESTLESSNESS 1 0.0000
63 HEPATIC FUNCTION ABNORMAL 1 0.0000
64 DYSARTHRIA 1 0.0000
65 HALLUCINATION 2 0.0000
66 ABNORMAL BEHAVIOUR 1 0.0000
67 DYSKINESIA 1 0.0000
68 CARDIAC ARREST 2 0.0000
69 CARDIO-RESPIRATORY ARREST 1 0.0000
70 MENTAL DISORDER 1 0.0000
71 THERAPEUTIC RESPONSE UNEXPECTED 1 0.0000
72 HEART RATE INCREASED 2 0.0000
73 AGGRESSION 1 0.0000
74 ACCIDENTAL EXPOSURE TO PRODUCT 2 0.0000
75 NERVOUSNESS 1 0.0000
76 SPEECH DISORDER 1 0.0000
77 DISTURBANCE IN ATTENTION 1 0.0000
78 DEPENDENCE 1 0.0000
79 MEDICATION ERROR 1 0.0000
80 HERPES ZOSTER 1 0.0000
81 LETHARGY 1 0.0000
82 SEIZURE 2 0.0000
83 INTENTIONAL OVERDOSE 1 0.0000
84 UNDERDOSE 1 0.0000
85 AGITATION 1 0.0000
86 UNEVALUABLE EVENT 1 0.0000
87 CHRONIC KIDNEY DISEASE 1 0.0000
88 BLOOD PRESSURE INCREASED 2 0.0000
89 FEELING ABNORMAL 3 0.0000
90 INTENTIONAL PRODUCT USE ISSUE 1 0.0000
91 DYSPHAGIA 1 0.0000
92 NEUROPATHY PERIPHERAL 1 0.0000
93 CONTUSION 1 0.0000
94 SYNCOPE 1 0.0000
95 ERYTHEMA 2 0.0000
96 SEPSIS 1 0.0000
97 WEIGHT INCREASED 2 0.0000
98 PALPITATIONS 1 0.0000
99 JOINT SWELLING 1 0.0000
100 HYPERHIDROSIS 1 0.0000
101 PERIPHERAL SWELLING 1 0.0000
102 DRUG INTERACTION 1 0.0000
103 PNEUMONIA 2 0.0000
104 DRUG DOSE OMISSION 1 0.0000
105 DIZZINESS 3 0.0000
106 CHEST PAIN 1 0.0000
107 PRODUCT USE ISSUE 1 0.0000
108 GAIT DISTURBANCE 1 0.0000
109 ALOPECIA 1 0.0000
110 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1 0.0000
111 HYPERTENSION 1 0.0000
112 CONSTIPATION 1 0.0000
113 INCORRECT DOSE ADMINISTERED 1 0.0000
114 PRODUCT USE IN UNAPPROVED INDICATION 1 0.0000
115 FATIGUE 3 0.0000
116 ANXIETY 1 0.0000
117 CONDITION AGGRAVATED 1 0.0000
118 DEATH 2 0.0000
119 OFF LABEL USE 2 0.0000
120 DRUG INEFFECTIVE 1 0.0000